English
Polski
Español
українська
Biologic drugs for treatment of macrophage activation syndrome
Are biologic drugs used in the treatment of macrophage activation syndrome?
2019-05-13
Are biologic drugs used in the treatment of macrophage activation syndrome?
How to manage a patient with macrophage activation syndrome?
Are atypical fractures a frequent adverse effect of bisphosphonates? What drugs should be used in such situations?
What is the relation between fractures and quality of life, morbidity, and mortality?
When should we suspect macrophage activation syndrome in patients with adult-onset Still disease?
Which classes of drugs should be avoided in elderly patients because of increased risk of fractures? Does this include selective serotonin reuptake inhibitors (SSRIs) commonly used to treat depression?
What is new in the diagnosis and treatment of systemic vasculitis?
Can bisphosphonates be used in patients with moderate renal impairment? What are the potential adverse effects of these drugs? Is denosumab a better choice in such patients?
What is new in the 2014 International Criteria for Behçet Disease?
